Research ArticleArticle
Comparative Persistence of Methotrexate and Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis
Michael D. George, Joshua F. Baker and Alexis Ogdie
The Journal of Rheumatology September 2019, jrheum.190299; DOI: https://doi.org/10.3899/jrheum.190299
Michael D. George
From the University of Pennsylvania, Division of Rheumatology, and Perelman School of Medicine, Department of Biostatistics, Epidemiology, and Informatics; Philadelphia Veterans Affairs Medical Center, Division of Rheumatology, Philadelphia, Pennsylvania, USA. This work was supported by the McCabe Foundation; the Rheumatology Research Foundation Scientist Development Award to MG; the US National Institute of Arthritis and Musculoskeletal and Skin Diseases at the National Institutes of Health (grant numbers K23 AR073931-01 to MG and R01 AR072363 to AO); and the US Veterans Affairs Clinical Science Research and Development (grant number I01 CX001703 to JB). Dr. Ogdie has received research grant funding to the University of Pennsylvania from Novartis and Pfizer. M.D. George, MD, MSCE, Instructor, University of Pennsylvania, Division of Rheumatology; J.F. Baker, MD, MSCE, Assistant Professor, Philadelphia VA Medical Center, Division of Rheumatology, and University of Pennsylvania; A. Ogdie, MD, MSCE, Assistant Professor, University of Pennsylvania, Division of Rheumatology, and Perelman School of Medicine, Department of Biostatistics, Epidemiology, and Informatics. Address correspondence to Dr. M.D. George, 5 White Building, 3400 Spruce St., Philadelphia, Pennsylvania 19104, USA. E-mail: Michael.george@uphs.upenn.edu. Accepted for publication August 22, 2019.
Joshua F. Baker
From the University of Pennsylvania, Division of Rheumatology, and Perelman School of Medicine, Department of Biostatistics, Epidemiology, and Informatics; Philadelphia Veterans Affairs Medical Center, Division of Rheumatology, Philadelphia, Pennsylvania, USA. This work was supported by the McCabe Foundation; the Rheumatology Research Foundation Scientist Development Award to MG; the US National Institute of Arthritis and Musculoskeletal and Skin Diseases at the National Institutes of Health (grant numbers K23 AR073931-01 to MG and R01 AR072363 to AO); and the US Veterans Affairs Clinical Science Research and Development (grant number I01 CX001703 to JB). Dr. Ogdie has received research grant funding to the University of Pennsylvania from Novartis and Pfizer. M.D. George, MD, MSCE, Instructor, University of Pennsylvania, Division of Rheumatology; J.F. Baker, MD, MSCE, Assistant Professor, Philadelphia VA Medical Center, Division of Rheumatology, and University of Pennsylvania; A. Ogdie, MD, MSCE, Assistant Professor, University of Pennsylvania, Division of Rheumatology, and Perelman School of Medicine, Department of Biostatistics, Epidemiology, and Informatics. Address correspondence to Dr. M.D. George, 5 White Building, 3400 Spruce St., Philadelphia, Pennsylvania 19104, USA. E-mail: Michael.george@uphs.upenn.edu. Accepted for publication August 22, 2019.
Alexis Ogdie
From the University of Pennsylvania, Division of Rheumatology, and Perelman School of Medicine, Department of Biostatistics, Epidemiology, and Informatics; Philadelphia Veterans Affairs Medical Center, Division of Rheumatology, Philadelphia, Pennsylvania, USA. This work was supported by the McCabe Foundation; the Rheumatology Research Foundation Scientist Development Award to MG; the US National Institute of Arthritis and Musculoskeletal and Skin Diseases at the National Institutes of Health (grant numbers K23 AR073931-01 to MG and R01 AR072363 to AO); and the US Veterans Affairs Clinical Science Research and Development (grant number I01 CX001703 to JB). Dr. Ogdie has received research grant funding to the University of Pennsylvania from Novartis and Pfizer. M.D. George, MD, MSCE, Instructor, University of Pennsylvania, Division of Rheumatology; J.F. Baker, MD, MSCE, Assistant Professor, Philadelphia VA Medical Center, Division of Rheumatology, and University of Pennsylvania; A. Ogdie, MD, MSCE, Assistant Professor, University of Pennsylvania, Division of Rheumatology, and Perelman School of Medicine, Department of Biostatistics, Epidemiology, and Informatics. Address correspondence to Dr. M.D. George, 5 White Building, 3400 Spruce St., Philadelphia, Pennsylvania 19104, USA. E-mail: Michael.george@uphs.upenn.edu. Accepted for publication August 22, 2019.
Article Figures & Data
Additional Files
Data Supplement
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Comparative Persistence of Methotrexate and Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis
Michael D. George, Joshua F. Baker, Alexis Ogdie
The Journal of Rheumatology Sep 2019, jrheum.190299; DOI: 10.3899/jrheum.190299